BDX Stock Price

Volume
52 Week High
52 Week Low

Copyright Nasdaq. Minimum 15 minutes delayed.
Stock Chart

Filter by content type

Investors Overview

Form 8-K

BD Announces Second FDA Emergency Use Authorization, CE Mark for New COVID-19 Molecular Diagnostic for Global Use

BD Announces Live Webcast Of Second Fiscal Quarter Earnings Conference Call

BD, BioGX Announce FDA Emergency Use Authorization for New COVID-19 Diagnostic for Use in U.S.

Form 3

Form 8-K

BD, BioMedomics Announce Launch of Rapid Serology Test to Detect Exposure to COVID-19

2019 - July 1 through December 31, 2019

2019 - July 1 through December 31, 2019 132.5 KB

2019 - January 1 through June 30, 2019

2019 - January 1 through June 30, 2019 129.1 KB

Form 8-K

Investor Highlights

Meet Jonathan

Moments after crossing the finish line of a half marathon, Jonathan went into cardiac arrest due to a congenital defect in his artery.

Drone Delivery Capabilities

See how BD and WeRobotics worked to advance drones for healthcare in the Peruvian Amazon

AMR Leadership

BD solutions to combat antimicrobial resistance